Aerovate Therapeutics Statistics
Total Valuation
AVTE has a market cap or net worth of $73.33 million. The enterprise value is -$4.87 million.
Important Dates
The last earnings date was Thursday, March 27, 2025, before market open.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTE has 28.99 million shares outstanding. The number of shares has increased by 8.55% in one year.
| Current Share Class | 28.99M |
| Shares Outstanding | 28.99M |
| Shares Change (YoY) | +8.55% |
| Shares Change (QoQ) | -0.87% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 45.83% |
| Float | 11.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.93, with a Debt / Equity ratio of 0.01.
| Current Ratio | 20.93 |
| Quick Ratio | 20.54 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -74.91% and return on invested capital (ROIC) is -49.87%.
| Return on Equity (ROE) | -74.91% |
| Return on Assets (ROA) | -44.88% |
| Return on Invested Capital (ROIC) | -49.87% |
| Return on Capital Employed (ROCE) | -97.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.32M |
| Employee Count | 30 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTE has paid $55,000 in taxes.
| Income Tax | 55,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.12% in the last 52 weeks. The beta is 1.00, so AVTE's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -91.12% |
| 50-Day Moving Average | 2.49 |
| 200-Day Moving Average | 2.66 |
| Relative Strength Index (RSI) | 55.27 |
| Average Volume (20 Days) | 66,095 |
Short Selling Information
The latest short interest is 4.31 million, so 14.87% of the outstanding shares have been sold short.
| Short Interest | 4.31M |
| Short Previous Month | 4.33M |
| Short % of Shares Out | 14.87% |
| Short % of Float | 36.02% |
| Short Ratio (days to cover) | 46.68 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -74.60M |
| Pretax Income | -82.13M |
| Net Income | -69.63M |
| EBITDA | -74.31M |
| EBIT | -74.60M |
| Earnings Per Share (EPS) | -$2.44 |
Full Income StatementBalance Sheet
The company has $78.62 million in cash and $417,000 in debt, giving a net cash position of $78.21 million or $2.70 per share.
| Cash & Cash Equivalents | 78.62M |
| Total Debt | 417,000 |
| Net Cash | 78.21M |
| Net Cash Per Share | $2.70 |
| Equity (Book Value) | 76.43M |
| Book Value Per Share | 2.64 |
| Working Capital | 76.29M |
Full Balance SheetCash Flow
| Operating Cash Flow | -71.20M |
| Capital Expenditures | n/a |
| Free Cash Flow | -71.20M |
| FCF Per Share | -$2.46 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |